XPhyto Therapeutics looking forward to "transformational" 2021 as it stands on the cusp of commercialization
XPhyto Therapeutics Corp (CSE:XPHY) (OTCQB:XPHYF) (FRA:4XT) is moving closer to commercializing its rapid COVID-19 PCR test in 2021, it told shareholders Monday.
In a business update, the life sciences accelerator said that it is “on the cusp of transformational change” as its product development programs, including the rapid PCR test, move through the laboratory and into the clinic.
Vancouver-based XPhyto and its German development partner 3a-diagnostics GmbH, are hoping to launch the rapid PCR test in the first quarter of 2021. The two companies are also developing and commercializing several low-cost oral biosensors targeted for commercial approval and product launch in late 2021.
READ: XPhyto Therapeutics and German partner complete successful validation of their COVID-19 RT-PCR test system
Things look busy on the drug formulations front as well, with plans to launch human pilot studies on four of XPhyto’s lead therapeutic products: a transdermal patch for Parkinson’s disease; a CBD oral/sublingual strip for treatment-resistant epilepsy; a THC oral/sublingual strip for anorexia and nausea, and a CBD:THC (1:1) oral/sublingual strip for multiple sclerosis-related spasticity.
As for XPhyto’s psychedelics initiatives, the company said it plans to expand its programs to produce psychedelic APIs on an industrial scale. In addition, it plans to launch new programs to develop psychedelic drug formulations, as well as integrate the therapeutic products into established clinical care programs for mental health-related indications.
XPhyto CEO Hugh Rogers told investors that the firm had made significant progress in its business initiatives in 2020.
“We have ambitious milestones for 2021 with multiple product launches on the horizon, multiple clinical drug programs underway, and an aggressive commitment to psychedelic medicine,” Rogers said in a statement. “I am extremely confident that our team can execute on the company’s business plan for 2021.”
Contact Angela at [email protected]
Follow her on Twitter @AHarmantas
Story by ProactiveInvestors
Source: http://www.proactiveinvestors.com/companies/news/938731/xphyto-therapeutics-looking-forward-to--transformational--2021-as-it-stands-on-the-cusp-of-commercialization-938731.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Please Help Support BeforeitsNews by trying our Natural Health Products below!
Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST
Order by Phone at 866-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST
Order by Phone at 866-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST
Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!
HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation.
Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.
MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser! Cleans out toxic buildup with oxygen!
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover - Reduces Smart Meter radiation by 96%! (See Video).
| Online: | |
| Visits: | 1,605,711,833 |
| Stories: | 8,138,082 |
Whistler Blowers, Insiders
